Showing results (51-60 of 104) with videos related to
Sort By:
Pageof 11
BMJ Open Diabetes Research & Care|May 15, 2018
Treatment choice, medication adherence and glycemic efficacy in people with type 2 diabetes: a UK clinical practice database studyJason Gordon, Phil McEwan, Iskandar Idris, et al.Biotechnology and Bioengineering|November 23, 2005
Role of erythrocyte deformability during capillary wettingRonghui Zhou, Jason Gordon, Andre F Palmer, et al.Diabetes, Obesity & Metabolism|December 28, 2016
Managing glycaemia in older people with type 2 diabetes: A retrospective, primary care-based cohort study, with economic assessment of patient outcomesJason Gordon, Phil McEwan, Marc Evans, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 9, 2013
Evaluation of insulin use and value for money in type 2 diabetes in the United kingdomJason Gordon, Marc Evans, Phil McEwan, et al.Clinical Obesity|September 27, 2021
Clinical cost evaluation and health benefits of post-bariatric intervention for patients with type 2 diabetes living in the UKMohammed Alkharaiji, Uchenna Anyanwagu, Thomas Crabtree, et al.Sleep Medicine Clinics|February 10, 2023
Partner Alliance to Enhance Efficacy and Adherence of CBT-IJason Gordon Ellis, Robert Meadows, Pamela Alfonso-Miller, et al.Nutrients|May 27, 2023
The Impact of Kiwifruit Consumption on the Sleep and Recovery of Elite AthletesRónán Doherty, Sharon Madigan, Alan Nevill, et al.Expert Review of Endocrinology & Metabolism|May 26, 2022
Intensive glycemic control and macrovascular, microvascular, hypoglycemia complications and mortality in older (age ≥60years) or frail adults with type 2 diabetes: a systematic review and meta-analysis from randomized controlled trial and observation studiesThomas Crabtree, Jael-Joy Ogendo, Yana Vinogradova, et al.International Journal of Nursing Studies|July 17, 2012
Best practices of formal new graduate nurse transition programs: an integrative reviewKathy L Rush, Monica Adamack, Jason Gordon, et al.Journal of Medical Economics|October 25, 2011
A cost-utility study of the use of pregabalin in treatment-refractory neuropathic painJason Gordon, Steven Lister, Matthew Prettyjohns, et al.Pageof 11